Click here to get full coverage on Precision Trading with Merus N.v. (MRUS) Risk Zones - news.stocktradersdaily.com

Precision Trading with Merus N.v. (MRUS) Risk Zones  news.stocktradersdaily.com

Precision Trading with Merus N.v. (MRUS) Risk Zones - news.stocktradersdaily.com

Click here to get full coverage on What Fibonacci levels say about MRUS rebound - July 2025 Closing Moves & Real-Time Buy Zone Alerts - newser.com

What Fibonacci levels say about MRUS rebound - July 2025 Closing Moves & Real-Time Buy Zone Alerts  newser.com

What Fibonacci levels say about MRUS rebound - July 2025 Closing Moves & Real-Time Buy Zone Alerts - newser.com

Click here to get full coverage on Why MRUS stock could be next big winner - 2025 Market Outlook & Weekly Breakout Watchlists - nchmf.gov.vn

Why MRUS stock could be next big winner - 2025 Market Outlook & Weekly Breakout Watchlists  nchmf.gov.vn

Why MRUS stock could be next big winner - 2025 Market Outlook & Weekly Breakout Watchlists - nchmf.gov.vn

Click here to get full coverage on Merus (MRUS): Assessing Valuation After Rapid Share Price Gains - Yahoo Finance

Merus (MRUS): Assessing Valuation After Rapid Share Price Gains  Yahoo Finance

Merus (MRUS): Assessing Valuation After Rapid Share Price Gains - Yahoo Finance

Click here to get full coverage on MRUS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Merus N.V. Is Fair to Shareholders - Business Wire

MRUS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Merus N.V. Is Fair to Shareholders  Business Wire

MRUS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Merus N.V. Is Fair to Shareholders - Business Wire

Click here to get full coverage on MRUS Surges: What’s Driving the Excitement? - StocksToTrade

MRUS Surges: What’s Driving the Excitement?  StocksToTrade

MRUS Surges: What’s Driving the Excitement? - StocksToTrade

Click here to get full coverage on 36 patients: Merus' petosemtamab shows preliminary antitumor activity and manageable safety in mCRC phase 2 - Stock Titan

36 patients: Merus' petosemtamab shows preliminary antitumor activity and manageable safety in mCRC phase 2  Stock Titan

36 patients: Merus' petosemtamab shows preliminary antitumor activity and manageable safety in mCRC phase 2 - Stock Titan

Click here to get full coverage on Merus (MRUS) Shares Promising Interim Findings from Phase 2 Canc - GuruFocus

Merus (MRUS) Shares Promising Interim Findings from Phase 2 Canc  GuruFocus

Merus (MRUS) Shares Promising Interim Findings from Phase 2 Canc - GuruFocus

Click here to get full coverage on $MRUS stock is up 36% today. Here's what we see in our data. - Quiver Quantitative

$MRUS stock is up 36% today. Here's what we see in our data.  Quiver Quantitative

$MRUS stock is up 36% today. Here's what we see in our data. - Quiver Quantitative

Click here to get full coverage on Genmab Buys Merus For $8bn: A Good Deal If Potential Is Converted Into Revenue (MRUS) - Seeking Alpha

Genmab Buys Merus For $8bn: A Good Deal If Potential Is Converted Into Revenue (MRUS)  Seeking Alpha

Genmab Buys Merus For $8bn: A Good Deal If Potential Is Converted Into Revenue (MRUS) - Seeking Alpha

Click here to get full coverage on Assessing Merus (MRUS) Valuation After Its Recent Share Price Surge - simplywall.st

Assessing Merus (MRUS) Valuation After Its Recent Share Price Surge  simplywall.st

Assessing Merus (MRUS) Valuation After Its Recent Share Price Surge - simplywall.st

Click here to get full coverage on Stocks making the biggest moves midday: CSX, Electronic Arts, Pony AI, Merus and more - CNBC

Stocks making the biggest moves midday: CSX, Electronic Arts, Pony AI, Merus and more  CNBC

Stocks making the biggest moves midday: CSX, Electronic Arts, Pony AI, Merus and more - CNBC

Click here to get full coverage on Key metrics from MRUS’s quarterly data - Forecast Cut & AI Forecast for Swing Trade Picks - newser.com

Key metrics from MRUS’s quarterly data - Forecast Cut & AI Forecast for Swing Trade Picks  newser.com

Key metrics from MRUS’s quarterly data - Forecast Cut & AI Forecast for Swing Trade Picks - newser.com

Click here to get full coverage on How MRUS stock responds to policy changes - Market Sentiment Report & High Yield Stock Recommendations - nchmf.gov.vn

How MRUS stock responds to policy changes - Market Sentiment Report & High Yield Stock Recommendations  nchmf.gov.vn

How MRUS stock responds to policy changes - Market Sentiment Report & High Yield Stock Recommendations - nchmf.gov.vn

Click here to get full coverage on GMAB Stock Soars 21.9% in a Month Following MRUS Acquisition Deal - Yahoo Finance

GMAB Stock Soars 21.9% in a Month Following MRUS Acquisition Deal  Yahoo Finance

GMAB Stock Soars 21.9% in a Month Following MRUS Acquisition Deal - Yahoo Finance

Click here to get full coverage on MERUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Merus N.V. - MRUS - Business Wire

MERUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Merus N.V. - MRUS  Business Wire

MERUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Merus N.V. - MRUS - Business Wire

Click here to get full coverage on Growth Report: Why MRUS stock could be next big winner - 2025 Market Sentiment & Stepwise Trade Signal Guides - nchmf.gov.vn

Growth Report: Why MRUS stock could be next big winner - 2025 Market Sentiment & Stepwise Trade Signal Guides  nchmf.gov.vn

Growth Report: Why MRUS stock could be next big winner - 2025 Market Sentiment & Stepwise Trade Signal Guides - nchmf.gov.vn

Click here to get full coverage on Merus (MRUS) Gains Validation With Zenocutuzumab Approval, Barclays Sees Growth Potential - Yahoo Finance

Merus (MRUS) Gains Validation With Zenocutuzumab Approval, Barclays Sees Growth Potential  Yahoo Finance

Merus (MRUS) Gains Validation With Zenocutuzumab Approval, Barclays Sees Growth Potential - Yahoo Finance

Click here to get full coverage on Is MRUS stock a safe investment in uncertain markets - July 2025 Levels & Fast Gain Swing Alerts - nchmf.gov.vn

Is MRUS stock a safe investment in uncertain markets - July 2025 Levels & Fast Gain Swing Alerts  nchmf.gov.vn

Is MRUS stock a safe investment in uncertain markets - July 2025 Levels & Fast Gain Swing Alerts - nchmf.gov.vn

Click here to get full coverage on Merus (MRUS) Price Target Raised at BMO After Positive Phase 2 Data - Yahoo Finance

Merus (MRUS) Price Target Raised at BMO After Positive Phase 2 Data  Yahoo Finance

Merus (MRUS) Price Target Raised at BMO After Positive Phase 2 Data - Yahoo Finance

Click here to get full coverage on Phase 2 interim data: Merus' petosemtamab to be presented in plenary at AACR Oct 24; poster on cancer stem cells - Stock Titan

Phase 2 interim data: Merus' petosemtamab to be presented in plenary at AACR Oct 24; poster on cancer stem cells  Stock Titan

Phase 2 interim data: Merus' petosemtamab to be presented in plenary at AACR Oct 24; poster on cancer stem cells - Stock Titan

Click here to get full coverage on Merus Announces Publication of an Abstract on Petosemtamab - GlobeNewswire

Merus Announces Publication of an Abstract on Petosemtamab  GlobeNewswire

Merus Announces Publication of an Abstract on Petosemtamab - GlobeNewswire

Click here to get full coverage on Merus N.V. (MRUS): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Yahoo Finance

Merus N.V. (MRUS): Among the Best Cancer Stocks to Invest in for Long-Term Gain  Yahoo Finance

Merus N.V. (MRUS): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Yahoo Finance

Click here to get full coverage on Merus (MRUS) Soars to New High on Genmab Merger at 41% Premium - Insider Monkey

Merus (MRUS) Soars to New High on Genmab Merger at 41% Premium  Insider Monkey

Merus (MRUS) Soars to New High on Genmab Merger at 41% Premium - Insider Monkey

Click here to get full coverage on Men’s basketball announces addition of Tyler Mrus - BYU Athletics

Men’s basketball announces addition of Tyler Mrus  BYU Athletics

Men’s basketball announces addition of Tyler Mrus - BYU Athletics

Click here to get full coverage on New Analyst Forecast: $MRUS Given $96.0 Price Target | MRUS Stock News - Quiver Quantitative

New Analyst Forecast: $MRUS Given $96.0 Price Target | MRUS Stock News  Quiver Quantitative

New Analyst Forecast: $MRUS Given $96.0 Price Target | MRUS Stock News - Quiver Quantitative

Click here to get full coverage on MRUS Shares Surge Amid Acquisition Talks - timothysykes.com

MRUS Shares Surge Amid Acquisition Talks  timothysykes.com

MRUS Shares Surge Amid Acquisition Talks - timothysykes.com

Click here to get full coverage on Merus (MRUS): Evaluating Valuation After 75% Three-Month Share Price Surge - simplywall.st

Merus (MRUS): Evaluating Valuation After 75% Three-Month Share Price Surge  simplywall.st

Merus (MRUS): Evaluating Valuation After 75% Three-Month Share Price Surge - simplywall.st

Click here to get full coverage on William Blair Maintains Merus(MRUS.US) With Hold Rating - 富途牛牛

William Blair Maintains Merus(MRUS.US) With Hold Rating  富途牛牛

William Blair Maintains Merus(MRUS.US) With Hold Rating - 富途牛牛

Click here to get full coverage on We Think Merus (NASDAQ:MRUS) Can Afford To Drive Business Growth - Yahoo Finance

We Think Merus (NASDAQ:MRUS) Can Afford To Drive Business Growth  Yahoo Finance

We Think Merus (NASDAQ:MRUS) Can Afford To Drive Business Growth - Yahoo Finance

Click here to get full coverage on CCORF Maintains Merus(MRUS.US) With Hold Rating, Maintains Target Price $97 - 富途牛牛

CCORF Maintains Merus(MRUS.US) With Hold Rating, Maintains Target Price $97  富途牛牛

CCORF Maintains Merus(MRUS.US) With Hold Rating, Maintains Target Price $97 - 富途牛牛

Click here to get full coverage on Morning Market Movers: JFB, MLTX, MTEK, LRMR, MRUS See Big Swings - RTTNews

Morning Market Movers: JFB, MLTX, MTEK, LRMR, MRUS See Big Swings  RTTNews

Morning Market Movers: JFB, MLTX, MTEK, LRMR, MRUS See Big Swings - RTTNews

Click here to get full coverage on BofA Maintains Buy Rating on Merus (MRUS), Lifts PT - Yahoo Finance

BofA Maintains Buy Rating on Merus (MRUS), Lifts PT  Yahoo Finance

BofA Maintains Buy Rating on Merus (MRUS), Lifts PT - Yahoo Finance

Click here to get full coverage on Merus (MRUS) Gains Validation With Zenocutuzumab Approval, Barclays Sees Growth Potential - Insider Monkey

Merus (MRUS) Gains Validation With Zenocutuzumab Approval, Barclays Sees Growth Potential  Insider Monkey

Merus (MRUS) Gains Validation With Zenocutuzumab Approval, Barclays Sees Growth Potential - Insider Monkey

Click here to get full coverage on SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EA, MRUS, HFWA, TIPT on Behalf of Shareholders - PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EA, MRUS, HFWA, TIPT on Behalf of Shareholders  PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EA, MRUS, HFWA, TIPT on Behalf of Shareholders - PR Newswire

Click here to get full coverage on Why Is Merus Stock Soaring Monday? - Genmab (NASDAQ:GMAB), Merus (NASDAQ:MRUS) - Benzinga

Why Is Merus Stock Soaring Monday? - Genmab (NASDAQ:GMAB), Merus (NASDAQ:MRUS)  Benzinga

Why Is Merus Stock Soaring Monday? - Genmab (NASDAQ:GMAB), Merus (NASDAQ:MRUS) - Benzinga

Click here to get full coverage on Oncology Innovator Merus to Showcase Multispecific Antibody Pipeline at Wells Fargo Healthcare Event - Stock Titan

Oncology Innovator Merus to Showcase Multispecific Antibody Pipeline at Wells Fargo Healthcare Event  Stock Titan

Oncology Innovator Merus to Showcase Multispecific Antibody Pipeline at Wells Fargo Healthcare Event - Stock Titan

Click here to get full coverage on Tyler Mrus Discusses Decision to Commit to BYU - Vanquish The Foe

Tyler Mrus Discusses Decision to Commit to BYU  Vanquish The Foe

Tyler Mrus Discusses Decision to Commit to BYU - Vanquish The Foe

Click here to get full coverage on Merus Awards Massive $15.7M Stock Options Package to Key New Hires in Oncology Push - Stock Titan

Merus Awards Massive $15.7M Stock Options Package to Key New Hires in Oncology Push  Stock Titan

Merus Awards Massive $15.7M Stock Options Package to Key New Hires in Oncology Push - Stock Titan

Click here to get full coverage on Genmab to acquire for $8B in cash (update) (GMAB:NASDAQ) - Seeking Alpha

Genmab to acquire for $8B in cash (update) (GMAB:NASDAQ)  Seeking Alpha

Genmab to acquire for $8B in cash (update) (GMAB:NASDAQ) - Seeking Alpha

Click here to get full coverage on Overcoming the pain: BYU’s Mrus battled past serious injury to reach his dream - heraldextra.com

Overcoming the pain: BYU’s Mrus battled past serious injury to reach his dream  heraldextra.com

Overcoming the pain: BYU’s Mrus battled past serious injury to reach his dream - heraldextra.com

Click here to get full coverage on Is Merus (NASDAQ:MRUS) the Best High Short Interest Stock to Buy Now? - Yahoo Finance

Is Merus (NASDAQ:MRUS) the Best High Short Interest Stock to Buy Now?  Yahoo Finance

Is Merus (NASDAQ:MRUS) the Best High Short Interest Stock to Buy Now? - Yahoo Finance

Click here to get full coverage on Barclays downgrades Merus stock to Equalweight, cuts price target on valuation - Investing.com

Barclays downgrades Merus stock to Equalweight, cuts price target on valuation  Investing.com

Barclays downgrades Merus stock to Equalweight, cuts price target on valuation - Investing.com

Click here to get full coverage on Genmab Makes A Big Bet With Merus N.V. Acquisition (NASDAQ:GMAB) - Seeking Alpha

Genmab Makes A Big Bet With Merus N.V. Acquisition (NASDAQ:GMAB)  Seeking Alpha

Genmab Makes A Big Bet With Merus N.V. Acquisition (NASDAQ:GMAB) - Seeking Alpha

Click here to get full coverage on $HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 1st Merus N.V. (NASDAQ: MRUS) - PR Newswire

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 1st Merus N.V. (NASDAQ: MRUS)  PR Newswire

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of 1st Merus N.V. (NASDAQ: MRUS) - PR Newswire

Click here to get full coverage on MRUS Downgraded to Market Perform by Leerink Partners with Raise - GuruFocus

MRUS Downgraded to Market Perform by Leerink Partners with Raise  GuruFocus

MRUS Downgraded to Market Perform by Leerink Partners with Raise - GuruFocus

Click here to get full coverage on Genmab to buy Dutch cancer drugmaker Merus for $8 billion - Reuters

Genmab to buy Dutch cancer drugmaker Merus for $8 billion  Reuters

Genmab to buy Dutch cancer drugmaker Merus for $8 billion - Reuters

Click here to get full coverage on Merus Enters Transaction Agreement with Genmab - TipRanks

Merus Enters Transaction Agreement with Genmab  TipRanks

Merus Enters Transaction Agreement with Genmab - TipRanks

Click here to get full coverage on Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket - Benzinga

Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket  Benzinga

Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket - Benzinga

Click here to get full coverage on Merus Announces Financial Results for the Second Quarter 2025 and Provides Business Update - GlobeNewswire

Merus Announces Financial Results for the Second Quarter 2025 and Provides Business Update  GlobeNewswire

Merus Announces Financial Results for the Second Quarter 2025 and Provides Business Update - GlobeNewswire

Click here to get full coverage on MRUS Shares Surge: An Opportunity Beckons? - StocksToTrade

MRUS Shares Surge: An Opportunity Beckons?  StocksToTrade

MRUS Shares Surge: An Opportunity Beckons? - StocksToTrade

Click here to get full coverage on Merus: Riding The Bispecific Wave In Oncology (NASDAQ:MRUS) - Seeking Alpha

Merus: Riding The Bispecific Wave In Oncology (NASDAQ:MRUS)  Seeking Alpha

Merus: Riding The Bispecific Wave In Oncology (NASDAQ:MRUS) - Seeking Alpha

Click here to get full coverage on Merus (MRUS) Experiences Surge with Significant Stock Price Incr - GuruFocus

Merus (MRUS) Experiences Surge with Significant Stock Price Incr  GuruFocus

Merus (MRUS) Experiences Surge with Significant Stock Price Incr - GuruFocus

Click here to get full coverage on Merus N.V. Announces Pricing of Public Offering of Common Shares - Yahoo Finance

Merus N.V. Announces Pricing of Public Offering of Common Shares  Yahoo Finance

Merus N.V. Announces Pricing of Public Offering of Common Shares - Yahoo Finance

Click here to get full coverage on Genmab Strikes $8 Billion Deal To Acquire Cancer-Focused Merus - Investor's Business Daily

Genmab Strikes $8 Billion Deal To Acquire Cancer-Focused Merus  Investor's Business Daily

Genmab Strikes $8 Billion Deal To Acquire Cancer-Focused Merus - Investor's Business Daily

Click here to get full coverage on SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EA and MRUS on Behalf of Shareholders - GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EA and MRUS on Behalf of Shareholders  GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates EA and MRUS on Behalf of Shareholders - GlobeNewswire

Click here to get full coverage on Genmab’s Strategic Acquisition of MRUS: A Long-Term Positive Move Enhancing Pipeline and Growth Potential - TipRanks

Genmab’s Strategic Acquisition of MRUS: A Long-Term Positive Move Enhancing Pipeline and Growth Potential  TipRanks

Genmab’s Strategic Acquisition of MRUS: A Long-Term Positive Move Enhancing Pipeline and Growth Potential - TipRanks

Click here to get full coverage on BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of  GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Click here to get full coverage on Merus Announces Financial Results for the Second Quarter 2025 and Provides Business Update - Stock Titan

Merus Announces Financial Results for the Second Quarter 2025 and Provides Business Update  Stock Titan

Merus Announces Financial Results for the Second Quarter 2025 and Provides Business Update - Stock Titan

Click here to get full coverage on Tyler Mrus hopes to be BYU’s next ‘Shot Doctor,’ filling the shoes of Trevin Knell - Yahoo Sports

Tyler Mrus hopes to be BYU’s next ‘Shot Doctor,’ filling the shoes of Trevin Knell  Yahoo Sports

Tyler Mrus hopes to be BYU’s next ‘Shot Doctor,’ filling the shoes of Trevin Knell - Yahoo Sports

Click here to get full coverage on Leerink Partners Maintains Merus(MRUS.US) With Hold Rating, Maintains Target Price $97 - 富途牛牛

Leerink Partners Maintains Merus(MRUS.US) With Hold Rating, Maintains Target Price $97  富途牛牛

Leerink Partners Maintains Merus(MRUS.US) With Hold Rating, Maintains Target Price $97 - 富途牛牛

Click here to get full coverage on MRUS: Joint Managers Lead Successful Offering | MRUS Stock News - GuruFocus

MRUS: Joint Managers Lead Successful Offering | MRUS Stock News  GuruFocus

MRUS: Joint Managers Lead Successful Offering | MRUS Stock News - GuruFocus

Click here to get full coverage on Insider Sale: COO & GC of $MRUS Sells 16,805 Shares - Quiver Quantitative

Insider Sale: COO & GC of $MRUS Sells 16,805 Shares  Quiver Quantitative

Insider Sale: COO & GC of $MRUS Sells 16,805 Shares - Quiver Quantitative

Click here to get full coverage on MRUS Analyst Rating Update: Guggenheim Downgrades to Neutral | M - GuruFocus

MRUS Analyst Rating Update: Guggenheim Downgrades to Neutral | M  GuruFocus

MRUS Analyst Rating Update: Guggenheim Downgrades to Neutral | M - GuruFocus

Click here to get full coverage on MRUS Analyst Rating Update: Canaccord Genuity Adjusts PT and Rat - GuruFocus

MRUS Analyst Rating Update: Canaccord Genuity Adjusts PT and Rat  GuruFocus

MRUS Analyst Rating Update: Canaccord Genuity Adjusts PT and Rat - GuruFocus

Click here to get full coverage on Wi-Fi 7 MRU OFDMA: Turning Rush Hour into Easy Street for Wireless Traffic - Cisco Blogs

Wi-Fi 7 MRU OFDMA: Turning Rush Hour into Easy Street for Wireless Traffic  Cisco Blogs

Wi-Fi 7 MRU OFDMA: Turning Rush Hour into Easy Street for Wireless Traffic - Cisco Blogs

Click here to get full coverage on Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model - GlobeNewswire

Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model  GlobeNewswire

MRUS

Price Chart

Key Statistics

Technicals

About MRUS

Latest News

Precision Trading with Merus N.v. (MRUS) Risk Zones - news.stocktradersdaily.com

What Fibonacci levels say about MRUS rebound - July 2025 Closing Moves & Real-Time Buy Zone Alerts - newser.com

Why MRUS stock could be next big winner - 2025 Market Outlook & Weekly Breakout Watchlists - nchmf.gov.vn

Advanced Charts

Top Gainers

Top Losers